UK-headquartered start-up Tenpoint Therapeutics has reeled in a commendable $70 million in first-round financing that will be used to develop its cell-based therapies for sight-robbing diseases. The ...

​In addition to Full Draw Stability, the PSE bows seem to have cracked the code on riser-to-limb length ratio, pivot point ...

The TX Ultra 29.5’s loading procedure is very similar to other TenPoint crossbows. Loading the bow is an intuitive and fast ...

DAUPHIN COUNTY, Pa. (WHTM) — A crossbow bolt was shot through a window and into a Dauphin County home, damaging the inside of it earlier this month. Two people are being sought by the Pennsylvania ...

Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that the Company ...

INDIANAPOLIS — Indy metro police and its community partners will be supported by up to 70 pairs of boots on the ground from dozens of Indianapolis churches and the TenPoint Coalition, which will walk ...

INDIANAPOLIS–The TenPoint Coalition plans to have a presence in Indianapolis all throughout the weekend, but especially on Saturday night with the WNBA All-Star game and the Indiana Black Expo taking ...

LONDON & SEATTLE, June 03, 2025--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd. ("Tenpoint"), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate ...

There’s just something about that yellow vest. Because it seems it’s all about the yellow vest. I had heard about the affection one veteran TenPointer had for his vest, and how during the months the ...

Brimochol PF, a combination of brimonidine and carbachol, was found to enhance depth of focus and visual acuity in clinical trials among patients with presbyopia. Tenpoint Therapeutics announced the ...

Please provide your email address to receive an email when new articles are posted on . The submission is supported by positive data from the phase 3 BRIO-I and BRIO-II studies. If approved, Brimochol ...

Tenpoint Therapeutics has tasked Carol Kearney with cracking a market that confounded AbbVie. As the biotech’s newly appointed chief commercial officer, Kearney will oversee preparations to launch a ...